Syntheses and biological evaluation of ring-C opened analogues of the cholinesterase inhibitors physostigmine, phenserine and cymserine

Medicinal Chemistry Research

Volumn 9, Issue 1, 1999, Pages 50-60

  Pei, Xue Feng ^a,c   Yu, Qian Sheng ^a   Holloway, Harold W ^a   Brossi, Arnold ^b   Greig, Nigel H ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Message Pharmaceutical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; CYMSERINE; PHENSERINE; PHYSOSTIGMINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHOLINESTERASE INHIBITION; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS;

EID: 0032926658     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Takano, S.; Ogasawara, K.The Alkaloids, 1989, 36, 225-251; and ref. cited therein.
2. Wolff, M.E. Burger's Medicinal Chemistry and Drug Discovery, Part IV. (Fifth Edition) J. Wiley and Sons, Inc., New York, NY, 1995.
3. Yu, Q.S.; Atack, J.R.; Rapoport, S.I.; Brossi, A.J. Med. Chem., 1988, 31, 2297.
4. Atack, J.R.; Yu, Q.S.; Soncrant, T.T.; Brossi, A.; Rapoport, S.I. J. Pharmacol. Exp. Ther., 1989, 249, 194-202.
5. Brzostowska, M., He, X.S., Greig, N.H., Brossi, A. Med. Chem. Res. 1992, 2, 238-246.
6. Pei, X.F.; Greig, N.H.; Brossi, A. Med. Chem. Res., 1995, 5, 455-461.
7. Pomponi, M.; Giacobini, E.; Brufani, M. Aging, 1990, 2, 125-153.
8. Pomponi, M.; Giardina, B.; Gatta, F.; Marta, M. Med. Chem. Res., 1992, 2, 306-312.
9. Yu, Q.S.; Liu, C.; Brzostowska, M.; Chrisey, L.; Brossi, A.; Greig, N.H.; Atack, J.R.; Soncrant, T.T.; Radunz, H.E. Helv. Chim. Acta 1991, 74, 761-766.
10. He, X.S.; Greig, N.H.; Rapoport, S.I.; Brossi, A.; Li, Y.Q.; Yu, Q.S. Med. Chem. Res. 1992, 2, 229-237.
11. An-naka, M.; Yasuda, K.; Yamada, M.; Kawai, A.; Takamura, N.; Sugasawa, S.; Matsuoka, Y.; Iwata, H.; Fukushima, T. Heterocycles, 1994, 39, 251-270.
12. Chen, Y.L.; Nielsen, J.; Hedberg, K.; Dunaiskis, A.; Jones, S.; Russo, L.; Johnson, J.; Ives, J.; Liston, D. J. Med. Chem, 1992, 35, 1429.
13. Sussman, J.L.; Havel, M.; Frolow, F.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I. Science, 1991, 253, 872-879.
14. Pei, X.F.; Greig, N.H.; Brossi, A. Heterocycles, 1998 (in press).
15. Greig, N. H.; Pei, X. F.; Soncrant, T; T; Ingram, D. K.; Brossi, A. Med. Res. Rev. 1995, 15, 3-31.
16. Brossi, A.; Pei, X. F.; Greig, N.H. Invited Review. Aust. J. Chem., 1996, 49, 171-181.
17. Greig, N.H.; Ingram, D.; Wallace, W.C.; Utsuki, T.; Yu, Q.S.; Holloway, H.W.; Pei, X.F.; Haroutunian, V.; Lahiri, D.; Brossi, A.; and Soncrant, T.T. In, Alzheimer's Disease: Molecular Biology to Therapy (eds, Becker, B.; Giacobini, E.; Robert, P), Birkhäuser, Boston, 1996, pp 231-237.
18. Haroutunian, V.; Greig, N.H.; Utsuki, T.; Davis, K.L.; and Wallace, W.C. Mol. Brain Res., 1997, 46, 161-168.
19. Robinson, B.; Robinson, J. B. J. Pharm, Pharmacol., 1968, 20, Suppl. 213S.
20. Dale, F.J.; Robinson, B. J. Pharm, Pharmacol., 1970, 22, 889-896; and ref. cited therein.
21. Jackson, A.H.; Smith, A.E. J. Chem. Soc., 1964, 5510-5517.
22. Pei, X.F.; Greig, N.H.; Bi, S.; Brossi, A.; Toome, V. Med. Chem. Res. 1995, 5, 265-270
23. Pei, X.F.; Greig, N.H.; Flippen-Anderson, J.L.; Bi, S.; Brossi, A. Helv. Chim. Acta 1994, 77, 1412-1421.
24. Greig, N.H. In, Physiology and Pharmacology of the Blood-Brain Barrier, Handbook of Experimantal Pharmacology, Vol. 103 (ed. Bradbury M.W.B.) Springer-Verlag, New York, NY, 1992, pp. 487-523.